MIG
NVAX icon

Mariner Investment Group’s Novavax NVAX Stock Holding History

Mariner Investment Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,060
Closed -$154K – 116
2016
Q2 		$154K Buy
+1,060
New +$121K 0.05% 118
2015
Q1 		– Sell
-2,295
Closed -$272K – 232
2014
Q4 		$272K Buy
+2,295
New +$240K 0.05% 194

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mariner Investment Group's NVAX Position: Q3 2016 in Review

Mariner Investment Group sold out of Novavax (NVAX) in Q3 2016, closing a stake of 1,060 shares — an estimated $154K sold.

Mariner Investment Group first reported a position in NVAX in Q4 2014 and held it in 2 quarters. The position peaked at $272K in Q4 2014. 165 funds tracked by Wall St. Rank hold NVAX as of Q3 2016.

  • Mariner Investment Group reported no remaining Novavax position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 1,060 Novavax shares in Q3 2016, an estimated $154K.
  • Mariner Investment Group first reported a position in Novavax in Q4 2014 and held it in 2 quarters.
  • Mariner Investment Group's Novavax position peaked at $272K in Q4 2014.
  • 165 funds tracked by Wall St. Rank held Novavax as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.